Study to Evaluate Efficacy and Safety of Mepolizumab for Frequently Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients
Clinical trial NCT02105948 · COMPLETED
Trial details
- NCT number
- NCT02105948
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-15
- Primary completion
- 2017-01-17
- Enrollment
- 837
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.